| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Chief Operating Officer | Common Stock | 407K | $3.2M | $7.86 | Aug 4, 2025 | Direct |
| ROCKET PHARMACEUTICALS, INC. | Chief Operating Officer | Stock Option (Right to Buy) | 554K | Aug 4, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | Aug 4, 2025 | 2 | $0 | 4 | Aug 6, 2025 | Chief Operating Officer |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Jul 7, 2025 | 0 | $0 | 3 | Aug 4, 2025 | Chief Operating Officer No securities beneficially owned. Exhibit 24: Power of Attorney |